Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,573,011
Closed -$270M 8495
2026
Q1
$270M Buy
3,573,011
+1,210,935
+51% +$91M 0.02% 799
2025
Q4
$176M Sell
2,362,076
-1,550,185
-40% -$113M 0.01% 1023
2025
Q3
$264M Buy
3,912,261
+1,552,180
+66% +$103M 0.02% 775
2025
Q2
$154M Sell
2,360,081
-7,848,701
-77% -$470M 0.01% 1024
2025
Q1
$631M Sell
10,208,782
-289,751
-3% -$19.2M 0.05% 393
2024
Q4
$757M Sell
10,498,533
-377,141
-3% -$29.5M 0.05% 334
2024
Q3
$886M Buy
10,875,674
+3,062,170
+39% +$245M 0.06% 279
2024
Q2
$580M Buy
7,813,504
+3,023,149
+63% +$227M 0.04% 386
2024
Q1
$373M Sell
4,790,355
-1,994,197
-29% -$148M 0.03% 549
2023
Q4
$485M Buy
6,784,552
+4,990,163
+278% +$347M 0.02% 691
2023
Q3
$125M Sell
1,794,389
-46,624
-3% -$3.52M 0.01% 935
2023
Q2
$149M Buy
1,841,013
+8,386
+0.5% +$685K 0.01% 855
2023
Q1
$148M Sell
1,832,627
-760,786
-29% -$61.2M 0.02% 830
2022
Q4
$194M Buy
2,593,413
+328,687
+15% +$23.4M 0.02% 699
2022
Q3
$146M Sell
2,264,726
-248,278
-10% -$17.2M 0.02% 711
2022
Q2
$174M Buy
2,513,004
+735,907
+41% +$54.6M 0.02% 649
2022
Q1
$137M Buy
1,777,097
+22,360
+1% +$1.61M 0.02% 685
2021
Q4
$134M Buy
1,754,737
+667,137
+61% +$49M 0.02% 723
2021
Q3
$80.3M Sell
1,087,600
-194,332
-15% -$14.6M 0.01% 966
2021
Q2
$85.5M Sell
1,281,932
-4,940
-0.4% -$330K 0.01% 946
2021
Q1
$95.7M Buy
1,286,872
+336,033
+35% +$25.5M 0.01% 784
2020
Q4
$69.2M Buy
950,839
+387,398
+69% +$27.3M 0.01% 892
2020
Q3
$37.5M Buy
563,441
+83,742
+17% +$5.3M 0.01% 1060
2020
Q2
$27.3M Sell
479,699
-214,486
-31% -$10.5M 0.01% 1194
2020
Q1
$24.4M Buy
694,185
+248,200
+56% +$11.8M 0.01% 1143
2019
Q4
$23.3M Sell
445,985
-148,353
-25% -$7.39M 0.01% 1531
2019
Q3
$30M Sell
594,338
-120,375
-17% -$5.92M 0.01% 1192
2019
Q2
$34.3M Buy
714,713
+168,257
+31% +$7.78M 0.01% 1084
2019
Q1
$26.4M Sell
546,456
-644,412
-54% -$29.1M 0.01% 1246
2018
Q4
$48.9M Buy
1,190,868
+468,820
+65% +$19.2M 0.01% 825
2018
Q3
$29.6M Sell
722,048
-221,488
-23% -$8.95M 0.01% 1336
2018
Q2
$37.5M Buy
943,536
+384,676
+69% +$14.8M 0.01% 1080
2018
Q1
$20.9M Sell
558,860
-302,313
-35% -$12.2M 0.01% 1623
2017
Q4
$36.8M Sell
861,173
-298,349
-26% -$11.9M 0.01% 1162
2017
Q3
$42.5M Buy
1,159,522
+164,159
+16% +$6.63M 0.01% 1003
2017
Q2
$45.2M Buy
995,363
+461,574
+86% +$20.4M 0.01% 967
2017
Q1
$22.7M Sell
533,789
-235,972
-31% -$9.62M 0.01% 1448
2016
Q4
$30.9M Sell
769,761
-8,356
-1% -$322K 0.01% 1179
2016
Q3
$30.2M Buy
778,117
+10,390
+1% +$392K 0.01% 1154
2016
Q2
$26.6M Sell
767,727
-1,499,232
-66% -$51.9M 0.01% 1207
2016
Q1
$78.2M Buy
2,266,959
+991,571
+78% +$34.6M 0.03% 552
2015
Q4
$49.3M Buy
1,275,388
+489,813
+62% +$19.1M 0.02% 790
2015
Q3
$30.7M Buy
785,575
+259,406
+49% +$10.3M 0.01% 1077
2015
Q2
$20M Sell
526,169
-277,513
-35% -$9.71M 0.01% 1501
2015
Q1
$26.5M Buy
803,682
+365,068
+83% +$11.2M 0.01% 1236
2014
Q4
$11.7M Sell
438,614
-468,917
-52% -$12.1M ﹤0.01% 1914
2014
Q3
$22.1M Buy
907,531
+193,300
+27% +$4.88M 0.01% 1361
2014
Q2
$18.1M Buy
714,231
+206,136
+41% +$4.82M 0.01% 1521
2014
Q1
$10.9M Buy
508,095
+101,077
+25% +$2.18M ﹤0.01% 1892
2013
Q4
$9.1M Buy
407,018
+7,608
+2% +$168K ﹤0.01% 2027
2013
Q3
$8.25M Sell
399,410
-142,355
-26% -$3.03M ﹤0.01% 1941
2013
Q2
$10.5M Buy
+541,765
New +$11.3M 0.01% 1665

Other funds holding HOLX

Morgan Stanley's HOLX Position: Q2 2026 in Review

Morgan Stanley sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,573,011 shares — an estimated $270M sold.

Morgan Stanley first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $886M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Morgan Stanley reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 3,573,011 Hologic shares in Q2 2026, an estimated $270M.
  • Morgan Stanley first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Morgan Stanley's Hologic position peaked at $886M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.